Citius Pharmaceuticals, Inc. Interest Expense
Citius Pharmaceuticals, Inc. (CTXR) reported Interest Expense of $198.33 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-08-14
- Citius Pharmaceuticals, Inc. interest expense for the quarter ending 2026-06-30 was $198.33K.
- Citius Pharmaceuticals, Inc. interest expense for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- Citius Pharmaceuticals, Inc. interest expense for the quarter ending 2021-06-30 was $2.93K, a 30.93% decline year-over-year.
- Citius Pharmaceuticals, Inc. interest expense for the quarter ending 2021-03-31 was $3.94K, a 1.03% decline year-over-year.
- Citius Pharmaceuticals, Inc. interest expense for fiscal 2021 was $10.84K, a 30.84% decline from fiscal 2020.
- Citius Pharmaceuticals, Inc. interest expense for fiscal 2020 was $15.67K, a 4.68% decline from fiscal 2019.
- Citius Pharmaceuticals, Inc. interest expense for fiscal 2019 was $16.44K, a 3.82% increase from fiscal 2018.
- Citius Pharmaceuticals, Inc. interest expense for fiscal 2018 was $15.84K, a 98.14% decline from fiscal 2017.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month | Interest Expense 16 month | Interest Expense 19 month | Interest Expense 22 month | Interest Expense 25 month | Interest Expense 28 month | Interest Expense 31 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $198.33K 10-Q · filed 2026-08-14 | |||||||||
| 2021-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-22 | $2.93K derived: sum of 2 quarters · filed 2022-12-22 | $6.87K derived: sum of 3 quarters · filed 2022-12-22 | $10.84K 10-K · filed 2022-12-22 | ||||||
| 2021-06-30 | $2.93K 10-Q · filed 2022-08-11 | $6.87K derived: sum of 2 quarters · filed 2022-08-11 | $10.84K 10-Q · filed 2022-08-11 | $14.30K derived: sum of 4 quarters · filed 2022-08-11 | ||||||
| 2021-03-31 | $3.94K 10-Q · filed 2021-05-13 | $7.91K 10-Q · filed 2021-05-13 | $11.36K derived: sum of 3 quarters · filed 2021-12-15 | $15.61K derived: sum of 4 quarters · filed 2021-12-15 | ||||||
| 2020-12-31 | $3.97K 10-Q · filed 2021-02-11 | $7.42K derived: sum of 2 quarters · filed 2021-12-15 | $11.67K derived: sum of 3 quarters · filed 2021-12-15 | $15.65K derived: sum of 4 quarters · filed 2021-12-15 | ||||||
| 2020-09-30 | $3.46K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-15 | $7.70K derived: sum of 2 quarters · filed 2021-12-15 | $11.68K derived: sum of 3 quarters · filed 2021-12-15 | $15.67K 10-K · filed 2021-12-15 | ||||||
| 2020-06-30 | $4.25K 10-Q · filed 2021-08-12 | $8.22K derived: sum of 2 quarters · filed 2021-08-12 | $12.22K 10-Q · filed 2021-08-12 | $16.41K derived: sum of 4 quarters · filed 2021-08-12 | ||||||
| 2020-03-31 | $3.98K 10-Q · filed 2021-05-13 | $7.97K 10-Q · filed 2021-05-13 | $12.17K derived: sum of 3 quarters · filed 2021-05-13 | $16.31K derived: sum of 4 quarters · filed 2021-05-13 | ||||||
| 2019-12-31 | $3.99K 10-Q · filed 2021-02-11 | $8.19K derived: sum of 2 quarters · filed 2021-02-11 | $12.33K derived: sum of 3 quarters · filed 2021-02-11 | $16.43K derived: sum of 4 quarters · filed 2021-02-11 | ||||||
| 2019-09-30 | $4.20K derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-16 | $8.34K derived: sum of 2 quarters · filed 2020-12-16 | $12.44K derived: sum of 3 quarters · filed 2020-12-16 | $16.44K 10-K · filed 2020-12-16 | ||||||
| 2019-06-30 | $4.14K 10-Q · filed 2020-08-14 | $8.24K derived: sum of 2 quarters · filed 2020-08-14 | $12.25K 10-Q · filed 2020-08-14 | $16.09K derived: sum of 4 quarters · filed 2020-08-14 | ||||||
| 2019-03-31 | $4.11K 10-Q · filed 2020-05-14 | $8.11K 10-Q · filed 2020-05-14 | $11.96K derived: sum of 3 quarters · filed 2020-05-14 | $15.86K derived: sum of 4 quarters · filed 2020-05-14 | ||||||
| 2018-12-31 | $4.00K 10-Q · filed 2020-02-13 | $7.85K derived: sum of 2 quarters · filed 2020-02-13 | $11.75K derived: sum of 3 quarters · filed 2020-02-13 | $16.46K derived: sum of 4 quarters · filed 2020-02-13 | ||||||
| 2018-09-30 | $3.85K derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-16 | $7.75K derived: sum of 2 quarters · filed 2019-12-16 | $12.45K derived: sum of 3 quarters · filed 2019-12-16 | $15.84K 10-K · filed 2019-12-16 | ||||||
| 2018-06-30 | $3.90K 10-Q · filed 2018-08-14 | $8.61K derived: sum of 2 quarters · filed 2019-08-14 | $11.99K 10-Q · filed 2019-08-14 | $796.00K derived: sum of 4 quarters · filed 2019-12-16 | ||||||
| 2018-03-31 | $4.71K 10-Q · filed 2019-05-15 | $8.09K 10-Q · filed 2019-05-15 | $792.10K derived: sum of 3 quarters · filed 2019-12-16 | $825.80K derived: sum of 4 quarters · filed 2019-12-16 | ||||||
| 2017-12-31 | $3.38K 10-Q · filed 2019-02-14 | $787.39K derived: sum of 2 quarters · filed 2019-12-16 | $821.09K derived: sum of 3 quarters · filed 2019-12-16 | $840.95K derived: sum of 4 quarters · filed 2019-12-16 | ||||||
| 2017-09-30 | $784.01K derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-16 | $817.71K derived: sum of 2 quarters · filed 2019-12-16 | $837.56K derived: sum of 3 quarters · filed 2019-12-16 | $850.79K 10-K · filed 2019-12-16 | ||||||
| 2017-06-30 | $33.70K 10-Q · filed 2018-08-14 | $53.55K derived: sum of 2 quarters · filed 2018-08-14 | $66.78K 10-Q · filed 2018-08-14 | $71.33K derived: sum of 4 quarters · filed 2018-12-11 | ||||||
| 2017-03-31 | $19.85K 10-Q · filed 2018-05-11 | $33.08K 10-Q · filed 2018-05-11 | $37.63K derived: sum of 3 quarters · filed 2018-12-11 | $42.07K derived: sum of 4 quarters · filed 2018-12-11 | ||||||
| 2016-12-31 | $13.23K 10-Q · filed 2018-02-14 | $17.78K derived: sum of 2 quarters · filed 2018-12-11 | $22.22K derived: sum of 3 quarters · filed 2018-12-11 | |||||||
| 2016-09-30 | $4.55K derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-11 | $8.99K derived: sum of 2 quarters · filed 2018-12-11 | $8.99K 10-K · filed 2018-12-11 | |||||||
| 2016-06-30 | $4.45K 10-Q · filed 2017-08-14 | $4.45K 10-Q · filed 2017-08-14 | ||||||||
| 2015-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-13 | $0.00 derived: sum of 2 quarters · filed 2017-12-13 | $0.00 derived: sum of 3 quarters · filed 2017-12-13 | $7.50K 10-K · filed 2017-12-13 | ||||||
| 2015-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-15 | $0.00 derived: sum of 2 quarters · filed 2016-08-15 | $7.50K 10-Q · filed 2016-08-15 | -$8.68K derived: sum of 4 quarters · filed 2016-12-23 | ||||||
| 2015-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-20 | $7.50K 10-Q · filed 2016-05-20 | -$8.68K derived: sum of 3 quarters · filed 2016-12-23 | $24.90K derived: sum of 4 quarters · filed 2016-12-23 | ||||||
| 2014-12-31 | $7.50K 10-Q · filed 2016-02-12 | -$8.68K derived: sum of 2 quarters · filed 2016-12-23 | $24.90K derived: sum of 3 quarters · filed 2016-12-23 | $65.35K derived: sum of 4 quarters · filed 2016-12-23 | ||||||
| 2014-09-30 | -$16.18K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-23 | $17.40K derived: sum of 2 quarters · filed 2016-12-23 | $93.07K 10-K · filed 2015-12-14 | $93.07K 10-K · filed 2016-12-23 | ||||||
| 2014-06-30 | $33.58K 10-Q · filed 2015-08-13 | $74.03K derived: sum of 2 quarters · filed 2015-08-13 | $109.25K 10-Q · filed 2015-08-13 | |||||||
| 2014-03-31 | $40.45K 10-Q · filed 2015-05-13 | $75.67K 10-Q · filed 2015-05-13 | ||||||||
| 2013-12-31 | $35.22K 10-Q · filed 2015-02-17 | $105.47K 10-K · filed 2015-12-14 | ||||||||
| 2013-03-31 | $893.00 10-Q · filed 2013-05-13 | $1.68K 10-Q · filed 2013-05-13 | $2.53K derived: sum of 3 quarters · filed 2013-05-13 | $3.18K derived: sum of 4 quarters · filed 2013-05-13 | $4.77K 10-Q · filed 2013-05-13 | |||||
| 2012-12-31 | $784.00 10-Q · filed 2013-02-08 | $1.63K derived: sum of 2 quarters · filed 2013-02-08 | $2.29K derived: sum of 3 quarters · filed 2013-02-08 | $33.31K 10-KT · filed 2014-12-29 | $3.88K 10-Q · filed 2013-02-08 | |||||
| 2012-09-30 | $850.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-01-15 | $1.50K derived: sum of 2 quarters · filed 2013-01-15 | $2.02K derived: sum of 3 quarters · filed 2013-05-13 | $2.39K 10-K · filed 2013-01-15 | $3.09K 10-K · filed 2013-01-15 | |||||
| 2012-06-30 | $655.00 10-Q · filed 2012-08-17 | $1.17K derived: sum of 2 quarters · filed 2013-05-13 | $1.54K 10-Q · filed 2012-08-17 | $1.85K derived: sum of 4 quarters · filed 2013-05-13 | $2.24K 10-Q · filed 2012-08-17 | |||||
| 2012-03-31 | $511.00 10-Q · filed 2013-05-13 | $883.00 10-Q · filed 2013-05-13 | $1.20K derived: sum of 3 quarters · filed 2013-05-13 | $1.42K derived: sum of 4 quarters · filed 2013-05-13 | $1.59K 10-Q · filed 2012-05-11 | |||||
| 2011-12-31 | $372.00 10-Q · filed 2013-02-08 | $689.00 derived: sum of 2 quarters · filed 2013-02-08 | $909.00 derived: sum of 3 quarters · filed 2013-02-08 | $1.06K derived: sum of 4 quarters · filed 2013-02-08 | $1.08K 10-Q · filed 2012-02-14 | |||||
| 2011-09-30 | $317.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-01-15 | $537.00 derived: sum of 2 quarters · filed 2013-01-15 | $691.00 derived: sum of 3 quarters · filed 2013-01-15 | $704.00 10-K · filed 2013-01-15 | ||||||
| 2011-06-30 | $220.00 10-Q · filed 2012-08-17 | $374.00 derived: sum of 2 quarters · filed 2012-08-17 | $387.00 10-Q · filed 2012-08-17 | |||||||
| 2011-03-31 | $154.00 10-Q · filed 2012-05-11 | $167.00 10-Q · filed 2012-05-11 | ||||||||
| 2010-12-31 | $13.00 10-Q · filed 2012-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |